Christopher Bowlus, MD
Enriched profileChief, Division of Gastroenterology and Hepatology; Lena Valente Professor, Department of Internal Medicine, UC Davis School of Medicine · University of California, Davis
Christopher Bowlus is Chief, Division of Gastroenterology and Hepatology; Lena Valente Professor, Department of Internal Medicine, UC Davis School of Medicine at University of California, Davis. OpenAlex indexes 434 publications with 17,169 citations (h-index 70); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Christopher Bowlus, MD, is Chief, Division of Gastroenterology and Hepatology at University of California, Davis, School of Medicine. The public record shows 434 publications with 17,169 citations (h-index 70), centered on Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Pediatric Hepatobiliary Diseases and Treatments. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 12 companies, 5 NIH-funded awards (1997–2015).
- Most recent indexed publication: 2026 · The American journal of gastroenterology
- Top research focus: Liver Diseases and Immunity
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 186.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Sponsor: LISCure Biosciences
- Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Sponsor: PSC Partners Seeking a Cure
- Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
Sponsor: COUR Pharmaceutical Development Company, Inc.
Industry payments
Updated 14 Oct 2026
12 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20259 payments
- Ipsen Biopharmaceuticals, IncProgram year20252 payments
- GlaxoSmithKline, LLC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
55.9%Bile Acid30.1%Ursodiol100%Part D≥52 patientsRifamycin Antibacterial8.4%Xifaxan100%Part D<11 patients+ 5 more classes in this area
Cardiovascular
18.4%Aldosterone antagonist (MRA)5.8%Spironolactone100%Part D≥13 patientsBeta blocker5.4%Carvedilol60%Propranolol Hcl41%Part D<11 patients+ 2 more classes in this area
Cancer & immunology
14.1%Purine Antimetabolite14.1%Azathioprine100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
5 NIH research awards on record, funded 1997–2015 per NIH RePORTER. The latest:
- SACRAMENTO COLLABORATIVE TO ADVANCE TESTING AND CARE OF HEPATITIS B (SCRATCH)
University of California at Davis
FY2015$326,667U51PS004633 - An Open-Label Study of Ursolkc Acid for Primary Sclerosing Cholangitis
University of California at Davis
FY2015$179,043R21DK100897 - SACRAMENTO COLLABORATIVE TO ADVANCE TESTING AND CARE OF HEPATITIS B (SCRATCH)
University of California at Davis
FY2014$300,000U51PS004633
Congress activity
Updated 14 Oct 2026
1 congress contribution (2016) across AMCP per OpenAlex. The most recent:
- Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update
AMCP Meeting
AMCP2016Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.
The American journal of gastroenterology
Article2026 - Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.
Hepatology communications
Clinical Trial2026 - Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.
The American journal of gastroenterology
Article2026 - Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study.
The American journal of gastroenterology
Article2025 - Spatial heterogeneity in liver stiffness does not predict clinical outcomes in patients with primary sclerosing cholangitis.
Hepatology communications
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/christopher-bowlus-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Christopher-Bowlus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/christopher-bowlus-45336870
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Apple Podcasts
podcasts.apple.com/ie/podcast/christopher-bowlus-md-addressing-challenges-in-management/id252080751
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Other
aasld.org/the-liver-meeting/speakers/christopher-l-bowlus-49128
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Other
hcplive.com/authors/christopher-bowlus-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - LinkedIn
LinkedIn profile: "Christopher Bowlus - Professor - UC Davis" (auth-walled, corroborated via SERP snippet only)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Doximity
Doximity profile: Dr. Christopher Bowlus, MD, Sacramento, CA, Gastroenterology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.ucdavis.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physicians.ucdavis.edu ↗
Editorial & leadership roles
journal and society appointments- Chief
Division of Gastroenterology and Hepatology, UC Davis School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗ - Lena Valente Professor
UC Davis Department of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗ - Professor in Residence
MED: Internal Medicine - Gastroenterology, UC Davis School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdavis.edu ↗ - Principal Investigator
multiple NIH-funded research initiatives on autoimmune liver disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdavis.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗
- Fellow
American Association for the Study of Liver Diseases (FAASLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Secondary affiliations
appointments beyond the home institution- Member
Microbiome Research Working Group, UC Davis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →microbiome.ucdavis.edu ↗ - UC Davis Medical Group - Davis (secondary clinical site)
2440 West Covell Blvd, Suite 104, Davis, CA 95616
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicians.ucdavis.edu ↗
Media & interviews
press, podcasts and appearances- Living With PSC podcast
Episode 15: "Dr. Christopher Bowlus, Drug and Clinical Development for PSC Treatment" (PSC Partners Seeking a Cure)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pscpartners.libsyn.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- American Liver Foundation "Ask the Experts" webinar on Autoimmune Hepatitis and Primary Sclerosing Cholangitis
featuring Christopher Bowlus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverfoundation.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dmr.amegroups.org ↗
- GI leader profile feature
Becker's ASC: "GI leader to know: Dr. Christopher Bowlus of UC Davis Health"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beckersasc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Rogawski, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
Carroll Cross, MD
University of California, Davis
Soe Thein, MD
University of California, Davis
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH